Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine

There are limited long-term data on seroprevalence of neutralising antibody (nAb) to the three poliovirus serotypes following the switch from oral polio vaccine (OPV) to inactivated polio vaccine (IPV). In Australia, combination vaccines containing IPV replaced OPV in late 2005. Using serum and plas...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2020-03, Vol.38 (11), p.2572-2577
Main Authors: Hendry, Alexandra J., Beard, Frank H., Dey, Aditi, Quinn, Helen, Hueston, Linda, Dwyer, Dominic E., McIntyre, Peter B.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Adults
Age groups
Aged
Aged, 80 and over
Allergy and Immunology
Antibodies
Antibodies, Neutralizing - blood
Antibodies, Viral - blood
Australia
Australia - epidemiology
blood serum
Child
Child, Preschool
Enterovirus C
Estimates
Ethics
Gender
Humans
Immunity
Immunization Schedule
Immunization, Secondary
Inactivated polio vaccine
Infant
Laboratories
Measles
Middle Aged
neutralizing antibodies
Polio
Poliomyelitis
Poliomyelitis - epidemiology
Poliomyelitis - prevention & control
Poliovirus - classification
Poliovirus - immunology
Poliovirus Vaccine, Inactivated - administration & dosage
Poliovirus Vaccine, Oral - administration & dosage
Population
Schedules
Seroepidemiologic Studies
seroprevalence
Serosurveillance
Serosurvey
Serotypes
travel
Vaccines
Viruses
Young Adult
Young adults
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!